Related Experiment Video
Updated: Aug 20, 2026
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Advances in understanding the molecular pathogenesis of neoplastic hematologic disorders
1Medical Laboratory Sciences Program at Oakland University, Rochester, MI 48309-4482, USA. jlwillia@oakland.edu
Insights
This summary covers key advancements in hematology from the 45th ASH meeting. It highlights new findings in myeloproliferative neoplasms, myelodysplastic syndromes, and acute leukemias.
Area of Science:
- Hematology
- Oncohematology
Background:
- The 45th Annual Meeting of the American Society of Hematology (ASH) convened in December 2003.
- The meeting featured significant advancements in hematology education and research.
- There was a notable increase in the presence of the American Society for Clinical Laboratory Science (ASCLS).
Purpose of the Study:
- To disseminate key information from the 45th ASH meeting to colleagues unable to attend.
- To provide insights into specific areas of hematologic research and clinical practice.
- To summarize developments in myeloproliferative disorders, myelodysplastic syndromes, and acute leukemias.
Main Methods:
- The authors attended the 45th ASH meeting.
- Key scientific developments were identified and selected for review.
- Information was curated for dissemination in subsequent publications.
Main Results:
- The meeting showcased exciting new developments in hematology.
- Educational programs and exhibits provided comprehensive scientific exchange.
- Specific focus areas included myeloproliferative disorders, myelodysplastic syndromes, acute lymphocytic leukemias, and acute myelocytic leukemias.
Conclusions:
- The 45th ASH meeting was a significant event for hematology professionals.
- Selected updates on leukemias and myeloproliferative/myelodysplastic syndromes are presented.
- Further information will be shared in upcoming issues of CLS.
Abstract:
The 45th Annual Meeting of the American Society of Hematology was held December 6-9, 2003, at the San Diego Convention Center in California. As with past meetings, there were exciting new developments, comprehensive educational programs, and phenomenal exhibits. There was also an ever increasing ASCLS presence at the meeting, as more hematology/hemostasis educators and researchers are finding their way to this very excellent scientific meeting. A group of us who attended the meeting would like to share with our colleagues who were unable to attend some of the new information in select areas, covered in the following two articles with a third to follow in the next issue of CLS. While a comprehensive summary of the entire meeting would be desirable, the scope of the meeting makes such an endeavor unfeasible. Consequently, we have chosen the areas of myeloproliferative disorders and myelodysplastic syndromes, acute lymphocytic leukemias, and acute myelocytic leukemias.
Related Concept Videos
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:21Hematopoiesis
01:01Regulation of Hematopoietic Stem Cells
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...